Aclaris raises $91M in follow-on

Aclaris Therapeutics Inc. (NASDAQ:ACRS) raised $91 million through the sale of 4 million shares at $22.75 in a follow-on underwritten by Jefferies, Leerink, Guggenheim Securities, William Blair and JPM Securities. The company proposed to raise up to $65 million after market hours Wednesday, when it closed at $22.86. It gained $0.96 to $23.82 on Thursday, and priced the offering after market close...